Advanced in Chronic T-Cell Leukemia (CTCL)

Amit S. Khot

St. Andrews Place, 
East Melbourne, VIC, AU 
Advanced in Chronic T-Cell Leukemia (CTCL)
St. Andrews Place, 
East Melbourne, VIC, AU 
OverviewLocationsClinical Research

Overview

Amit Khot practices in East Melbourne, Australia. Mr. Khot is rated as an Advanced expert by MediFind in the treatment of Chronic T-Cell Leukemia (CTCL). His top areas of expertise are Peripheral T-Cell Lymphoma, Chronic T-Cell Leukemia (CTCL), Prolymphocytic Leukemia, Osteotomy, and Bone Marrow Transplant.

His clinical research consists of co-authoring 60 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years. In particular, he has co-authored 3 articles in the study of Chronic T-Cell Leukemia (CTCL).

Gender
Male

Locations

St. Andrews Place, East Melbourne, VIC, Australia
Other Locations
50 Flemington Road, Parkville, VIC 3052, Australia
Flemington Road, Parkville, VIC 3052, Australia

Clinical Research

Clinical research consists of overseeing clinical studies of patients undergoing new treatments and therapies, and publishing articles in peer reviewed medical journals. Experts who actively participate in clinical research are generally at the forefront of the fields and aware of the most up-to-date advances in treatments for their patients.

1 Clinical Trials

A Phase I/II, Open-label, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-Drug Conjugate GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed / Refractory Multiple Myeloma - DREAMM-6
A Phase I/II, Open-label, Dose Escalation and Expansion Study to Evaluate Safety, Tolerability, and Clinical Activity of the Antibody-Drug Conjugate GSK2857916 Administered in Combination With Lenalidomide Plus Dexamethasone (Arm A), or Bortezomib Plus Dexamethasone (Arm B) in Participants With Relapsed / Refractory Multiple Myeloma - DREAMM-6
Enrollment Status: Completed
Publish Date: March 18, 2025
Intervention Type: Drug
Study Drugs: Belantamab Mafodotin, Lenalidomide, Dexamethasone, Bortezomib
Study Phase: Phase 1/Phase 2

60 Total Publications

Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy.
Ribosome Biogenesis and Function in Cancer: From Mechanisms to Therapy.
Journal: Cancers
Published: June 19, 2025

Areas of Expertise

MediFind evaluates expertise by pulling from factors such as number of articles a doctor has published in medical journals, participation in clinical trials, speaking at industry conferences, prescribing and referral patterns, and strength of connections with other experts in their field.

Learn more about MediFind’s expert tiers

Find Mr. Khot's expertise for a condition
ConditionClose
      View All 23 Experienced Conditions
      Want to save this expert for later?
      Sign Up
      Not sure about your diagnosis?
      Check Your Symptoms
       
       
       
       
      Learn about our expert tiers
      Learn More
      Are you the provider on this profile?
      Claim Profile